Gender-Age Distribution of Patients with COVID-19 at Different Stages of Epidemic in Moscow

The ongoing COVID-19 pandemic around the world and in Russia remains a major event of 2020. All over the world, research is being conducted to comprehensively study the patterns and manifestations of the epidemic  process. The main quantitative characteristics of SARS-CoV-2 transmission dynamics among the population, based on the data of official monitoring over the current situation, play an important role in the development of  the epidemiological surveillance system.

The aim of this study is to explore the peculiarities of age-gender distribution of COVID-19 patients in Moscow.

Material and methods. The data related to the epidemiological characteristics of age-gender structure of COVID-19 patients in Moscow between March 19, 2020 and April 15, 2020, at different stages of the  epidemic were retrospectively analyzed.

Results and discussion. The mean age of COVID-19 patients in Moscow was 46,41±20,58 years. The gender ratio (male/female) among the patients was 52.7/47.3 %, wherein the indicators varied depending upon the  age. Male/female ratio in the age group “under 39” stood at 53.7/46.3 %, and “over 40 years of age” – at  39.3/60.7 %. The predominant age range among male cases was 19 to 39 years old – 35.4 %, while among female patients – 40–59 years (36.5 %). The age distribution of patients in Moscow is indicative of the fact that COVID-19 is a disease that primarily affects older age groups. The age structure of all COVID-19 cases during the observation period is characterized by predominance of adult patients over 19 years of age – 92,7 % (92,6–92,8 %), the share of patients aged 40–59 years is 35,7% (35,5–35,9 %). The differences in the age distribution in males and females are as follows: in the male cohort, the age groups 19–39 years old and 40–59 years old prevail – 35.4 % (35.1–35.7 %) and 34.9 % (34.6–35.2 %), respectively. The age group 40–59 years old – 36.5 % (36.3–36.8%) dominates in the female cohort. 

1. Lechien J.R., Chiesa-Estomba C.M., Place S., Laethem Y.V., Cabaraux P., Mat Q., Huet K., Plzak J., Horoi M., Hans S., Barillari M.R., Cammaroto G., Fakhry N., Martiny D., Ayad T., Jouffe L., Hopkins C., Saussez S. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J. Intern. Med. 2020; 30;10.1111/joim.13089. DOI: 10.1111/joim.13089.

2. Conti P., Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J. Biol. Regul. Homeost. Agents. 2020; 34(2):339–43. DOI: 10.23812/Editorial-Conti-3.

3. Petrilli C.M., Jones S.A., Yang J., Rajagopalan H., O’Donnell L., Chernyak Y., Tobin K.A., Cerfolio R.J., Francois F., Horwitz L.I. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020; 369:m1966. DOI: 10.1136/bmj.m1966.

4. Suleyman G., Fadel R.A., Malette K.M., Hammond C., Abdulla H., Entz A., Demertzis Z., Hanna Z., Failla A., Dagher C., Chaudhry Z., Vahia A., Lanfranco O.A., Ramesh M., Zervos M.J., Alangaden G., Miller J., Brar I. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in Metropolitan Detroit. JAMA Netw. Open. 2020; 3(6):e2012270. DOI: 10.1001/jamanetworkopen.2020.12270.

5. Vaganov P.D., Yanovskaya E.Yu., Mandzhieva E.T. [Childhood periods]. Rossiisky Meditsynsky Zhurnal [Russian Medical Journal]. 2018; 24(4):185–90. DOI: 10.18821/0869-2106-2018-24-4-185-190.

6. Belyakov V.D., Degtyarev A.A., Ivannikov Yu.G. [The Quality and Effectiveness of Anti-Epidemic Measures]. L.: Meditsyna; 1981. 304 p.

7. Meskina E.R. [Preliminary clinical and epidemiological analysis of the first 1000 cases of COVID-19 in children in the Moscow Region]. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2020; 97(3);202–15. DOI: 10.36233/0372-9311-2020-97-3-2.

8. Akimkin V.G., Kuzin S.N., Semenenko T.A., Shipulina O.Yu., Yatsyshina S.B., Tivanova E.V., Kalenskaya A.V., Solovyova I.V., Vershinina M A.A., Kvasova O.A., Ploskireva A.A., Mamoshina M.V., Elkina M.A., Klushkina V.V., Andreeva E.E., Ivanenko A.V. [Patterns of the epidemic spread of SARS-CoV-2 in a metropolis]. Voprosy virusologii [Virology Issues]. 2020; 65(4):203–11. DOI: 10.36233/0507-4088-2020-65-4-203-211.

9. Ludvigsson J.F. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088–95. DOI: 10.1111/apa.15270.

10. Dhochak N., Singhal T., Kabra S.K., Lodha R. Pathophysiology of COVID-19: why children fare better than adults? Indian J Pediatr. 2020; 87(7):537–46. DOI: 10.1007/s12098-020-03322-y.

11. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiology of COVID-19 among children in China. Pediatrics. 2020; 145(6):e20200702.DOI: 10.1542/peds.2020-0702.

12. She J., Liu L., Liu W. COVID-19 epidemic: disease characteristics in children. J. Med. Virol. 2020; 92(7):747–54. DOI: 10.1002/jmv.25807.

13. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children – United States, February 12 – April 2, 2020. MMWR Morb. Mortal. Wkly Rep. 2020; 69(14):422–26. DOI: 10.15585/mmwr.mm6914e4.

14. Remuzzi A., Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020; 395(10231):1225–8. DOI: 10.1016/S0140-6736(20)30627-9.

15. A.J., Alishiri G.H., Heydari S., Ebrahimnia M., Samadinia H., Sepandi M., Jafari N.J., Izadi M., Qazvini A., Dorostkar R., Tat M., Shahriary A., Farnoosh G., Zijoud S.R.H., Taghdir M., Alimohamadi Y., Abbaszadeh S., Ghaleh H.E.G., Bagheri M. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J. Clin. Virol. 2020; 127:104378. DOI: 10.1016/j.jcv.2020.104378.

16. Martín-Sánchez F.J., Del Toro E., Cardassay E., Carbó A.V., Cuesta F., Vigara M., Gil P., Picado A.L.L., Valero C.M., Miranda J.D., Lopez-Ayala P., Chaparro D., López G.C., Suárez-Cadenas M.D.M., Fernández P.J., Angós B., Arco C.D.D., Adrada E.R., Moraleda M.T.M., Paeres C.E., Alonso C.F., Elvira C., Chacón A., Briñón M.Á.G., Rueda J.L.F., Ortega L., Pérez C.F., Armengol J.J.G., Del Castillo J.G. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department. Eur. Geriatr. Med. 2020; 1–13. DOI: 10.1007/s41999-020-00359-2.

17. Gudbjartsson D.F., Helgason A., Jonsson H., Magnusson O.T., Melsted P., Norddahl G.L., Saemundsdottir J., Sigurdsson A., Sulem P., Agustsdottir A.B., Eiriksdottir B., Fridriksdottir R., Gardarsdottir E.E., Georgsson G., Gretarsdottir O.S., Gudmundsson K.R., Gunnarsdottir T.R., Gylfason A., Holm H., Jensson B.O., Jonasdottir A., Jonsson F., Josefsdottir K.S., Kristjansson T., Magnusdottir D.N., le Roux L., Sigmundsdottir G., Sveinbjornsson G., Sveinsdottir K.E., Sveinsdottir M., Thorarensen E.A., Thorbjornsson B., Löve A., Masson G., Jonsdottir I., Möller A.D., Gudnason T., Kristinsson K.G., Thorsteinsdottir U., Stefansson K. Spread of SARS-CoV-2 in the Icelandic population. N. Engl. J. Med. 2020; 382(24):2302–15. DOI: 10.1056/NEJMoa2006100.

18. Gujski M., Raciborski F., Jankowski M., Nowicka P.M., Rakocy K., Pinkas J. Epidemiological analysis of the first 1389 cases of COVID-19 in Poland: A Preliminary Report. Med. Sci. Monit. 2020; 26:e924702. DOI: 10.12659/MSM.924702.

19. Sebastiani G., Massa M., Riboli E. Covid-19 epidemic in Italy: evolution, projections and impact of government measures. Eur. J. Epidemiol. 2020; 35(4):341–5. DOI: 10.1007/s10654-020-00631-6.

20. Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W., Drosten C., Vollmar P., Zwirglmaier K., Zange S., Wölfel R., Hoelscher M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 2020; 382(10):970–1. DOI: 10.1056/NEJMc200146.

21. Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson S., Tural A., Diaz G., Cohn A., Fox LeAnne, Patel A., Gerber S.I., Kim L., Tong S., Lu X., Lindstrom S., Pallansch M.A., Weldon W.C., Biggs H.M., Uyeki T.M., Pillai S.K. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 2020; 382(10):929–36. DOI: 10.1056/NEJMoa2001191.

22. Yang P., Huang L.K. Successful prevention of COVID-19 outbreak at elderly care institutions in Taiwan. J. Formos Med. Assoc. 2020; 119(8):1249–50. DOI: 10.1016/j.jfma.2020.05.024.

23. Fisman D.N., Bogoch I., Lapointe-Shaw L., McCready J., Tuite A.R. Risk factors associated with mortality among residents with coronavirus disease 2019 (COVID-19) in long-term care facilities in Ontario, Canada. JAMA Netw. Open. 2020; 3(7):e2015957. DOI: 10.1001/jamanetworkopen.2020.15957.

24. Nanda A., Vura N.V.R.K., Gravenstein S. COVID-19 in older adults. Aging Clin. Exp. Res. 2020; 32(7):1199–202. DOI: 10.1007/s40520-020-01581-5.

25. Nicol G.E., Piccirillo J.F., Mulsant B.H., Lenze E.J. Action at a distance: geriatric research during a pandemic. J. Am. Geriatr. Soc. 2020; 68(5):922–5. DOI: 10.1111/jgs.16443.

26. Koeberle S., Tannou T., Bouiller K., Becoulet N., Outrey J., Chirouze C., Aubry R. COVID-19 outbreak: organisation of a geriatric assessment and coordination unit. A French example. Age Ageing. 2020; 49(4):516–22. DOI: 10.1093/ageing/afaa092.